Crystallization of truncated human apolipoprotein A-I in a novel conformation

被引:24
作者
Borhani, DW [1 ]
Engler, JA
Brouillette, CG
机构
[1] So Res Inst, Dept Organ Chem, Birmingham, AL 35205 USA
[2] Univ Alabama Birmingham, Med Ctr, Dept Biochem & Mol Genet, Birmingham, AL 35294 USA
[3] Univ Alabama Birmingham, Med Ctr, Ctr Macromol Crystallog, Birmingham, AL 35294 USA
来源
ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY | 1999年 / 55卷
关键词
D O I
10.1107/S0907444999008914
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
The crystallization of recombinant human apolipoprotein A-I (apo A-I), the major protein component of high-density lipoprotein, in a new crystal form is described, The fragment crystallized, residues 44-243 of native apo A-I [apo Delta(1-43)A-I], is very similar to intact native apo A-I in its ability to bind lipid, to be incorporated into high-density lipoproteins and to activate lecithin-cholesterol acyl transferase, Apo a(1-43)A-I crystallizes, in the presence of beta-D-octylglucopyranoside, in space group I222 or I2(1)2(1)2(1), with unit-cell parameters a = 37.11, b = 123.62, c = 164.65 Angstrom and a diffraction limit of 3.2 Angstrom These form II crystals grow under conditions of significantly lower ionic strength than the original form I crystals (space group P2(1)2(1)2(1), a = 97.47, b = 113.87, c = 196.19 Angstrom, diffraction limit 3.0 Angstrom). Packing arguments show that the unusual open conformation of apo a(1-43)A-I found in the form I crystals cannot be packed into the smaller oddly proportioned form IZ unit cell, Monomeric apo Delta(1-43)A-I, as either a four-helix bundle (similar to 75 x 30 x 30 A) or an extended helical rod (similar to 150 x 20 x 20 Angstrom), can be packed into the form II unit cell. It is concluded, therefore, that ape Delta(1-43)A-I may have crystallized in one of these distinct conformations in the form II crystals.
引用
收藏
页码:1578 / 1583
页数:6
相关论文
共 31 条
  • [1] Identification of scavenger receptor SR-BI as a high density lipoprotein receptor
    Acton, S
    Rigotti, A
    Landschulz, KT
    Xu, SZ
    Hobbs, HH
    Krieger, M
    [J]. SCIENCE, 1996, 271 (5248) : 518 - 520
  • [2] THE CCP4 SUITE - PROGRAMS FOR PROTEIN CRYSTALLOGRAPHY
    BAILEY, S
    [J]. ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY, 1994, 50 : 760 - 763
  • [3] Crystal structure of truncated human apolipoprotein A-I suggests a lipid-bound conformation
    Borhani, DW
    Rogers, DP
    Engler, JA
    Brouillette, CG
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (23) : 12291 - 12296
  • [4] STRUCTURAL MODELS OF HUMAN APOLIPOPROTEIN-A-I
    BROUILLETTE, CG
    ANANTHARAMAIAH, GM
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA-LIPIDS AND LIPID METABOLISM, 1995, 1256 (02): : 103 - 129
  • [5] CARTER CW, 1979, J BIOL CHEM, V254, P2219
  • [6] INCIDENCE OF CORONARY HEART-DISEASE AND LIPOPROTEIN CHOLESTEROL LEVELS - THE FRAMINGHAM-STUDY
    CASTELLI, WP
    GARRISON, RJ
    WILSON, PWF
    ABBOTT, RD
    KALOUSDIAN, S
    KANNEL, WB
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1986, 256 (20): : 2835 - 2838
  • [7] CATAPANO A, 1993, ATHEROSCLEROSIS REV, V24
  • [8] Evans W, 1997, CHEM BRIT, V33, P22
  • [9] TREATMENT OF NEGATIVE INTENSITY OBSERVATIONS
    FRENCH, S
    WILSON, K
    [J]. ACTA CRYSTALLOGRAPHICA SECTION A, 1978, 34 (JUL): : 517 - 525
  • [10] HIGH-DENSITY LIPOPROTEIN AS A PROTECTIVE FACTOR AGAINST CORONARY HEART-DISEASE - FRAMINGHAM STUDY
    GORDON, T
    CASTELLI, WP
    HJORTLAND, MC
    KANNEL, WB
    DAWBER, TR
    [J]. AMERICAN JOURNAL OF MEDICINE, 1977, 62 (05) : 707 - 714